Work

Daratumumab and venetoclax-based combined regimen for relapsed/refractory T-lymphoblastic leukemia/lymphoma

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-1568

Authors: Shan Shao, Chuxian Zhao, Huixia Liu, Chun Wang, JUN Zhu, Daolin Wei, Ying Jiang

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417011814

Cites:

Cited by:

Related to: